Pipeline

Product
Indications
Stage of Development
Lead Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Back of Eye
AG-73305
(anti-VEGF + disintegrins)
DME
nAMD
Other Retinal
Diseases
Disintegrin Platform
Other Retinal
Diseases
Front of Eye
AG-80308
(FPR agonist; in-licensed)
Dry Eye
Other Ocular
Inflammation Diseases
AG-86893
(tyrosine kinase inhibitor; 505(B)(2))
Pterygium
Product
Back of Eye
AG-73305
(anti-VEGF + disintegrins)
Stage of Development
Lead Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Indications
DME
Indications
nAMD
Indications
Other Retinal Diseases
Product
Disintegrin Platform
Stage of Development
Lead Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Indications
Other Retinal Diseases
Product
Front of Eye
AG-80308
(FPR agonist; in-licensed)
Stage of Development
Lead Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Indications
Dry Eye
Indications
Other Ocular
Inflammation Diseases
Product
AG-86893
(tyrosine kinase inhibitor; 505(B)(2))
Stage of Development
Lead Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Indications
Pterygium